BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 31, 2005
View Archived Issues
XenoPort advances XP-19986 into phase I trials
Read More
Xcyte Therapies refocuses resources and activities
Read More
Arius' ARH-460-16-2 antibody to be studied for IBD
Read More
Keryx finalizes SPA agreement for KRX-101
Read More
PhG-alpha1 shows effectiveness on NSCLC cells in lab test
Read More
NIAID opens phase I study of experimental avian flu vaccine
Read More
Tanox to acquire Sunol's tissue factor antagonist program
Read More
Dyax updates DX-88 progress for HAE
Read More
Praecis in discussions regarding German Plenaxis submission
Read More
Enrollment completed in phase I/II CLL study of HuMax-CD20
Read More
NS-2359 advanced into phase II
Read More
IND accepted for MORAb-003
Read More
J&J and Guidant merger registration declared effective
Read More
CG-53135-05 shows no immunogenicity in patients with chemotherapy-induced mucositis
Read More
New evidence confirms the benefits of finasteride in the prevention of prostate cancer
Read More
Gene therapy claimed for the treatment of pain
Read More
A method for predicting colorectal cancer reported by Chiron
Read More
New treatments for cancer disclosed by Roche
Read More
New patents cover treatments for Alzheimer's disease
Read More
AZD-0865 effectively blocks acid output in preclinical tests
Read More
PHA-533533 displays a desirable anticancer preclinical profile
Read More
KMI-429 reduces beta-amyloid production in mice
Read More
VDM-11 produces antitussive effect in mice
Read More
12,14-Di-Cl-DHAA improves survival of postischemic myocytes
Read More
Approvable letter for Combidex
Read More
Takeda discontinues antidiabetic agent TAK-559
Read More
Enbrel launched in Japan
Read More
Eisai seeks European approval of Inovelon for Lennox-Gastaut Syndrome
Read More
Baraclude receives FDA approval
Read More
Zofran approved for children aged one month and older
Read More
Depo-subQ provera 104 approved for management of endometriosis pain
Read More
Once-monthly Boniva receives FDA approval
Read More